• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket

    11/16/23 8:08:28 AM ET
    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $AFIB alert in real time by email

    Shares of Palo Alto Networks, Inc. (NASDAQ:PANW) fell in pre-market trading after reporting first-quarter results.

    Palo Alto Networks reported quarterly earnings of $1.38 per share, above the analyst consensus estimate of $1.16. Revenue of $1.88 billion beat the analyst consensus estimate of $1.84 billion.

    Billings clocked in at $2.024 billion, a 13.6% increase compared to $1.749 billion in the same period of 2022. Full-year 2024 total billings are expected to be in a range $10.7 billion to $10.8 billion, down from prior forecast of $10.9 billion to $11 billion.

    Palo Alto Networks fell 5.2% to $242.82 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Bone Biologics Corporation (NASDAQ:BBLG) shares rose 62.1% to $0.8427 in pre-market trading after gaining around 9% on Wednesday.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) shares surged 37.4% to $0.0513 in pre-market trading after falling around 12% on Wednesday.
    • Chanson International Holding (NASDAQ:CHSN) shares rose 20.7% to $1.75 in pre-market trading after dipping 35% on Wednesday.
    • Acutus Medical, Inc. (NASDAQ:AFIB) shares rose 20.2% to $0.25 in pre-market trading after jumping around 24% on Wednesday. Acutus Medical recently reported third-quarter financial results and announced strategic realignment of resources and corporate restructuring by approximately 65%.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) rose 18.5% to $0.8181 in pre-market trading after gaining over 10% on Wednesday.
    • BioVie Inc. (NASDAQ:BIVI) shares climbed 14.3% to $3.60 in pre-market trading.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) shares rose 14.1% to $0.1712 in pre-market trading after falling around 17% on Wednesday.
    • SenesTech, Inc. (NASDAQ:SNES) rose 11.2% to $0.2013 in pre-market trading. SenesTech announced a 1-for-12 reverse stock split.
    • CISO Global Inc. (NASDAQ:CISO) gained 10.6% to $0.1769 in pre-market trading. CISO Global shares jumped 67% on Wednesday after the company announced its participation in the Microsoft Security Copilot Partner Private Preview.
    • CRISPR Therapeutics AG (NASDAQ:CRSP) shares rose 5.8% to $59.50 in pre-market trading. -Vertex Pharmaceuticals and CRISPR Therapeutics said that the U.K. Medicines and Healthcare products Regulatory Agency has granted conditional marketing authorization for CASGEVY, a CRISPR/Cas9 gene-edited therapy, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia.

    Losers

    • Volcon, Inc. (NASDAQ:VLCN) dipped 23.1% to $0.50 in pre-market trading after dipping 15% on Wednesday.
    • Augmedix, Inc. (NASDAQ:AUGX) shares fell 22.8% to $4.19 in pre-market trading after the company reported pricing of upsized public offering of 6,250,000 shares of common stock.
    • Velo3D, Inc. (NYSE:VLD) shares fell 16.3% to $1.18 in pre-market trading.
    • Alpine 4 Holdings, Inc. (NASDAQ:ALPP) shares fell 14.4% to $0.82 in pre-market trading.
    • Chemomab Therapeutics Ltd. (NASDAQ:CMMB) fell 14.1% to $0.7020 in pre-market. Chemomab Therapeutics shares jumped 34% on Wednesday after the company announced it received FDA fast track designation for CM-101 for the treatment of primary sclerosing cholangitis.
    • Sadot Group Inc. (NASDAQ:SDOT) shares fell 12.3% to $0.5035 in pre-market trading. Sadot Group shares fell around 20% on Wednesday after the company reported a wider third-quarter loss.
    • Streamline Health Solutions, Inc. (NASDAQ:STRM) fell 11.2% to $0.3045 in pre-market trading after declining 4% on Wednesday.
    • Cisco Systems, Inc. (NASDAQ:CSCO) shares fell 11% to $47.43 in pre-market trading. Cisco reported upbeat earnings for its first quarter but lowered its earnings and sales projections for FY24.
    • Moxian (BVI) Inc (NASDAQ:MOXC) shares fell 10.8% to $0.91 in pre-market trading.

     

    Now Read This: Gossamer Bio And 2 Other Stocks Under $1 Insiders Are Buying

    Get the next $AFIB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFIB
    $ALPP
    $AUGX
    $BBLG

    CompanyDatePrice TargetRatingAnalyst
    Palo Alto Networks Inc.
    $PANW
    3/3/2026$185.00Sell → Buy
    Arete
    Cisco Systems Inc.
    $CSCO
    2/18/2026Buy → Hold
    Erste Group
    Palo Alto Networks Inc.
    $PANW
    2/18/2026$230.00 → $200.00Outperform
    BMO Capital Markets
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    Palo Alto Networks Inc.
    $PANW
    1/5/2026Sell → Neutral
    Guggenheim
    Palo Alto Networks Inc.
    $PANW
    12/17/2025$235.00Overweight → Neutral
    Analyst
    Palo Alto Networks Inc.
    $PANW
    11/21/2025$157.00Hold → Reduce
    HSBC Securities
    Cisco Systems Inc.
    $CSCO
    11/10/2025Hold → Buy
    Erste Group
    More analyst ratings

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

    Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.  (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of artificial intelligence ("AI"), today announced that its MyoVista Insights™ platform has received Epic Toolbox designation for the ECG Management System category. MyoVista Insights is a cloud-native ECG management and analysis platform designed to enhance workflow efficiency and support clinical decision-making. The platform supports integration with hospital information systems and electronic health records ("EHRs"), including

    3/25/26 8:30:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

    Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.  (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of artificial intelligence ("AI"), will present at Investor Summit Group Virtual Conference, March 25, 2026 at 12:30 pm ET. Hosted by Investor Summit Group, a premier platform connecting microcap companies with leading investors, the event provides a highly efficient forum for emerging growth companies to engage directly with institutional investors, family offices, and high-net-worth individuals. Event Details: Conference: Inves

    3/24/26 11:18:08 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    Palo Alto Networks Secures Agentic AI with Prisma AIRS 3.0

    Delivering end-to-end discovery, risk assessment and protection across the agentic lifecycle SANTA CLARA, Calif., March 23, 2026 /PRNewswire/ -- Palo Alto Networks (NASDAQ:PANW), the global cybersecurity leader, today advances its AI security platform with the launch of Prisma® AIRS™ 3.0. As organizations transition toward a future defined by autonomous agents, Prisma AIRS 3.0 secures the entire Agentic AI lifecycle – enabling enterprises to move from simply observing AI interactions to safely authorizing autonomous execution.The shift toward an AI-powered enterprise introduces systemic security challenges – ranging from unmanaged Shadow AI to the critical new frontiers of agentic identity,

    3/23/26 6:35:00 PM ET
    $PANW
    Computer peripheral equipment
    Technology

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Palo Alto Networks upgraded by Arete with a new price target

    Arete upgraded Palo Alto Networks from Sell to Buy and set a new price target of $185.00

    3/3/26 8:20:38 AM ET
    $PANW
    Computer peripheral equipment
    Technology

    Cisco downgraded by Erste Group

    Erste Group downgraded Cisco from Buy to Hold

    2/18/26 9:41:39 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    BMO Capital Markets reiterated coverage on Palo Alto Networks with a new price target

    BMO Capital Markets reiterated coverage of Palo Alto Networks with a rating of Outperform and set a new price target of $200.00 from $230.00 previously

    2/18/26 6:52:21 AM ET
    $PANW
    Computer peripheral equipment
    Technology

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Arora Nikesh

    4 - Palo Alto Networks Inc (0001327567) (Issuer)

    3/27/26 6:11:23 PM ET
    $PANW
    Computer peripheral equipment
    Technology

    SEC Form 3 filed by new insider Takenaka Yoji

    3 - Tokyo Lifestyle Co., Ltd. (0001836242) (Issuer)

    3/26/26 12:52:12 PM ET
    $TKLF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Sato Tetsuya

    3 - Tokyo Lifestyle Co., Ltd. (0001836242) (Issuer)

    3/26/26 12:51:53 PM ET
    $TKLF
    Other Specialty Stores
    Consumer Discretionary

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Palo Alto Networks Inc.

    SCHEDULE 13G/A - Palo Alto Networks Inc (0001327567) (Subject)

    3/27/26 11:18:54 AM ET
    $PANW
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Cisco Systems Inc.

    SCHEDULE 13G/A - CISCO SYSTEMS, INC. (0000858877) (Subject)

    3/26/26 5:12:51 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    SEC Form SCHEDULE 13D filed by BioVie Inc.

    SCHEDULE 13D - BIOVIE INC. (0001580149) (Subject)

    3/25/26 5:00:26 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Leadership Updates

    Live Leadership Updates

    View All

    CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT

    Experienced AI and enterprise IT operations leader joins Company to accelerate scalable growth, strengthen security architecture, and advance next-generation cyber software innovation Scottsdale, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Dhaval Damania as Executive Vice President of Cybersecurity & IT. This appointment reinforces its continued commitment to operational excellence, innovation, and scalable growth across its next-generation cybersecurity software portfolio. In this role, Damania will lead CISO Global's

    2/23/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    CISO Global Lands 30 Year Sales Veteran Michael Czerneda to Ignite the Next Wave of Software Growth

    New Vice President of Sales to accelerate software-driven growth across cyber services platform and insurance distribution channels  Scottsdale, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Michael Czerneda as Vice President of Sales. In this role, Czerneda will lead enterprise-wide sales initiatives as the Company accelerates its transition toward scalable, software-driven growth built on its established cyber services platform.  Czerneda brings more than 30 years of sales leadership experience spanning UCaaS, CCaaS, da

    2/18/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Financials

    Live finance-specific insights

    View All

    SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

    SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 HighlightsRevenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of Evolve® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate re

    3/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern timePHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, will report financial results for its fourth quarter and fiscal year 2025, ended December 31, 2025, after the market close on Thursday, March 12, 2026. The Company has scheduled a conference call that same day, Thursday, March 12, 2026, at 5:00 pm ET, to review the results. Fourth Quarter and Fiscal Year 2024 Conference Call DetailsDa

    3/9/26 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $AFIB
    $ALPP
    $AUGX
    $BBLG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by CRISPR Therapeutics AG

    SC 13G/A - CRISPR Therapeutics AG (0001674416) (Subject)

    12/10/24 1:34:45 PM ET
    $CRSP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Chemomab Therapeutics Ltd.

    SC 13D/A - Chemomab Therapeutics Ltd. (0001534248) (Subject)

    11/29/24 3:04:59 PM ET
    $CMMB
    Biotechnology: Pharmaceutical Preparations
    Health Care